LITTLE FALLS, N.J.,
Feb. 23, 2015 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN) further expanded
its infection prevention and control portfolio with the acquisition
of MRLB International, the manufacturer of the DentaPure product
line for $10 million in cash
consideration. The DentaPure product line is a proprietary,
iodinated resin filter cartridge system used by dentists to
maintain safe water quality in dental unit waterlines. The
DentaPure cartridge system surpasses all standards and CDC
recommendations for dental unit water quality, thus maintaining
safe water quality for patients and staff. The DentaPure
cartridge systems, which are sold throughout the US and
Canada, have FDA 510(k)
certifications and are EPA registered as dental unit waterline
disinfectants.
This transaction is expected to be neutral to GAAP EPS in FY15
and slightly accretive to Non-GAAP EPS in FY15 and accretive to
both GAAP and Non-GAAP EPS in FY16 and beyond. The
DentaPure product line will be integrated into the Crosstex
portfolio and reported in the Healthcare Disposables segment.
Gary Steinberg, President and CEO
of Crosstex stated, "Dental unit waterline disinfection is one of
the fastest growing segments in the infection control category in
the dental industry. DentaPure's strong market position with
a high-quality, differentiated product portfolio allows Crosstex to
be a market leader in this important segment for our dental
customers. When combined with our leading biological
monitoring portfolio, DentaPure positions Crosstex as the clear
infection prevention and control compliance leader in the dental
industry."
About Cantel Medical Corp.
Cantel Medical Corp.
(NYSE:CMN) Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention and control products and
services for patients, caregivers, and other healthcare providers
which improve outcomes, enhance safety and help save lives.
Our products include specialized medical device reprocessing
systems for endoscopy and renal dialysis, advanced water
purification equipment, sterilants, disinfectants and cleaners,
sterility assurance monitoring products for hospitals and dental
clinics, disposable infection control products primarily for dental
and GI endoscopy markets, dialysate concentrates, hollow fiber
membrane filtration and separation products, and specialty
packaging for infectious and biological specimens. Additionally, we
provide technical service for our products. For further
information, visit the Cantel website at www.cantelmedical.com.
About Crosstex, Inc.
A subsidiary of Cantel Medical
Corp., Crosstex was founded in 1953 and has headquarters and major
manufacturing operations in Hauppauge, New York. Sold
throughout the world, Crosstex branded and private label products
include sterilization packaging and assurance products and
services, face masks, patient towels and bibs, disinfectants,
germicidal wipes, hand care products, gloves and protective
eyewear. For further information visit the Crosstex website
at www.crosstex.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cantel-medical-acquires-dentapure-dental-waterline-disinfection-system-300039356.html
SOURCE Cantel Medical Corp.